Form4insider filings, from the source

SEC Form 4 · accession 0001280776-19-000015

IMMUNIC, INC. · IMUX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John Michael Dunn
Officer — General Counsel and Secretary
Period of report
Jan 11, 2019
Accepted (ET)
Jan 14, 2019 · 9:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F2,F1$19.03Jan 11, 2019D50,000D—Nov 16, 2024Common Stock50,0000D
Stock Option (right to buy)F2,F3$8.28Jan 11, 2019D45,000D—May 12, 2026Common Stock45,0000D
Stock Option (right to buy)F2,F4$3.20Jan 11, 2019D45,000D—Jun 9, 2027Common Stock45,0000D
Stock Option (right to buy)F2,F5$5.00Jan 11, 2019D45,000D—Jun 8, 2028Common Stock45,0000D
Restricted Stock UnitsF6,F7—Jan 11, 2019A724,848A——Common Stock724,848724,848D

Explanation of responses